Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients
ConclusionTaking together, the SCF plasma level can serve as a novel diagnostic blood-circulating biomarker for patients with GBM. However, its plasma level is not correlated with GBM patients ’ tumor volume, PFS, or OS.
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Amirhosein Kefayat,
Alireza Amouheidari,
Fatemeh Ghahremani,
Zahra Alirezaei Tags: ORIGINAL RESEARCH Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Neurology | Stem Cell Therapy | Stem Cells | Study